Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
出版年份 2020 全文链接
标题
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-30
DOI
10.1038/s41598-020-69744-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure
- (2019) Erika Ponzini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models
- (2019) Panagiota Mavroeidi et al. ACTA NEUROPATHOLOGICA
- 14-3-3/Tau Interaction and Tau Amyloidogenesis
- (2019) Yuwen Chen et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
- (2019) Michal Wegrzynowicz et al. ACTA NEUROPATHOLOGICA
- Distinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains
- (2019) Thomas K. Karikari et al. Frontiers in Cellular Neuroscience
- Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression
- (2019) Martin Bartels et al. Scientific Reports
- Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
- (2019) Matthias Brendel et al. Alzheimers Research & Therapy
- Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies
- (2019) Éva M. Szegő et al. Cell Reports
- Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
- (2019) Johannes Levin et al. LANCET NEUROLOGY
- α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
- (2019) Michael X. Henderson et al. NEUROSCIENCE LETTERS
- Questions EMERGE as Biogen claims aducanumab turnaround
- (2019) Robert Howard et al. Nature Reviews Neurology
- Photophysics of diphenyl-pyrazole compounds in solutions and α-synuclein aggregates
- (2018) Anne M. Reiner et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Near-atomic model of microtubule-tau interactions
- (2018) Elizabeth H. Kellogg et al. SCIENCE
- Small Molecules Attenuate the Interplay between Conformational Fluctuations, Early Oligomerization and Amyloidosis of Alpha Synuclein
- (2018) Sumanta Ghosh et al. Scientific Reports
- Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways
- (2018) Lewis D. Evans et al. Cell Reports
- Fulvic Acid Inhibits Aggregation and Promotes Disassembly of Tau Fibrils Associated with Alzheimer's Disease
- (2018) Alberto Cornejo et al. JOURNAL OF ALZHEIMERS DISEASE
- Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
- (2018) Jordi Pujols et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
- (2018) Neha Atulkumar Singh et al. Frontiers in Aging Neuroscience
- Membrane binding, internalization, and sorting of alpha-synuclein in the cell
- (2018) Caterina Masaracchia et al. Acta Neuropathologica Communications
- Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
- (2018) Antonio Heras-Garvin et al. MOVEMENT DISORDERS
- Global Burden of Neurological Disorders: From Global Burden of Disease Estimates to Actions
- (2018) Valery L. Feigin et al. NEUROEPIDEMIOLOGY
- Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG
- (2018) Sneha Roy et al. PROTEIN SCIENCE
- α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease
- (2017) Sushil K Singh et al. Future Medicinal Chemistry
- A review on protein misfolding, aggregation and strategies to prevent related ailments
- (2017) Tooba Naz Shamsi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Metal chelator EGCG attenuates Fe(III)-induced conformational transition of α-synuclein and protects AS-PC12 cells against Fe(III)-induced death
- (2017) Juan Zhao et al. JOURNAL OF NEUROCHEMISTRY
- (−)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer’s disease
- (2017) Yufang Guo et al. NEUROREPORT
- Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death
- (2017) Elisa Turriani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Bi-fluorescence complementation system to detect associations between the Endoplasmic reticulum and mitochondria
- (2017) Mark Harmon et al. Scientific Reports
- Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids inPseudomonas aeruginosaand Increases Biofilm Susceptibility to Antibiotic Treatment
- (2016) Marcel Stenvang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Copper binding to soil fulvic and humic acids: NICA-Donnan modeling and conditional affinity spectra
- (2016) Jinling Xu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease
- (2016) Yan Xu et al. NEUROCHEMICAL RESEARCH
- Interference of α-Synuclein Uptake by Monomeric β-Amyloid1–40 and Potential Core Acting Site of the Interference
- (2016) Daniel K. Y. Chan et al. NEUROTOXICITY RESEARCH
- Two Small Molecules Block Oral Epithelial Cell Invasion by Porphyromons gingivalis
- (2016) Meng-Hsuan Ho et al. PLoS One
- Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
- (2016) Lisa Fellner et al. Frontiers in Neuroscience
- Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
- (2015) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice
- (2015) Ilie-Cosmin Stancu et al. ACTA NEUROPATHOLOGICA
- Dynasore - not just a dynamin inhibitor
- (2015) Giulio Preta et al. Cell Communication and Signaling
- Bimolecular Fluorescence Complementation (BiFC) Analysis: Advances and Recent Applications for Genome-Wide Interaction Studies
- (2015) Kristi E. Miller et al. JOURNAL OF MOLECULAR BIOLOGY
- Quantitative Real-Time Quaking-Induced Conversion Allows Monitoring of Disease-Modifying Therapy in the Urine of Prion-Infected Mice
- (2015) Song Shi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Determinants of amyloid fibril degradation by the PDZ protease HTRA1
- (2015) Simon Poepsel et al. Nature Chemical Biology
- A cell culture model for monitoring α-synuclein cell-to-cell transfer
- (2015) Juan F. Reyes et al. NEUROBIOLOGY OF DISEASE
- Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons
- (2015) Adrianne S. Chesser et al. NUTRITIONAL NEUROSCIENCE
- On the lag phase in amyloid fibril formation
- (2015) Paolo Arosio et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
- (2014) Johannes Levin et al. ACTA NEUROPATHOLOGICA
- Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
- (2014) Marcos J. Guerrero-Muñoz et al. BIOCHEMICAL PHARMACOLOGY
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- N′-[4-(dipropylamino)benzylidene]-2-hydroxybenzohydrazide is a dynamin GTPase inhibitor that suppresses cancer cell migration and invasion by inhibiting actin polymerization
- (2013) Hiroshi Yamada et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
- (2013) Seameen Dehdashti et al. Current Alzheimer Research
- Partial Peptide of α-Synuclein Modified with Small-Molecule Inhibitors Specifically Inhibits Amyloid Fibrillation of α-Synuclein
- (2013) Wataru Yoshida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors
- (2013) R. J. Park et al. JOURNAL OF CELL SCIENCE
- Tau Oligomers as Potential Targets for Alzheimer’s Diagnosis and Novel Drugs
- (2013) Leonardo Guzmán-Martinez et al. Frontiers in Neurology
- Can Nutraceuticals Prevent Alzheimer's Disease? Potential Therapeutic Role of a Formulation Containing Shilajit and Complex B Vitamins
- (2012) Carlos Carrasco-Gallardo et al. ARCHIVES OF MEDICAL RESEARCH
- The effect of fulvic acid on pre‐ and postaggregation state of Aβ17–42: Molecular dynamics simulation studies
- (2012) Sharad Verma et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes
- (2012) Ismael Santa-Maria et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of clathrin in mitotic spindle organisation
- (2012) S. J. Royle JOURNAL OF CELL SCIENCE
- Dynamin, a membrane-remodelling GTPase
- (2012) Shawn M. Ferguson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Dynamin Chemical Inhibitor Dynasore Impairs Cholesterol Trafficking and Sterol-Sensitive Genes Transcription in Human HeLa Cells and Macrophages
- (2011) Emmanuelle Girard et al. PLoS One
- Phospholipase C-dependent Ca2+-sensing pathways leading to endocytosis and inhibition of the plasma membrane vacuolar H+-ATPase in osteoclasts
- (2010) Hiromu Sakai et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity
- (2010) Fanling Meng et al. BIOCHEMISTRY
- Molecular mechanism of Thioflavin-T binding to amyloid fibrils
- (2010) Matthew Biancalana et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Zooming into protein oligomerization in neurodegeneration using BiFC
- (2010) Susana A. Gonçalves et al. TRENDS IN BIOCHEMICAL SCIENCES
- HPV16 and BPV1 Infection Can Be Blocked by the Dynamin Inhibitor Dynasore
- (2009) Cynthia Y Abban et al. AMERICAN JOURNAL OF THERAPEUTICS
- Overlapping functions of different dynamin isoforms in clathrin-dependent and -independent endocytosis in pancreatic β cells
- (2008) Jingze Lu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
- (2008) Kavon Rezai-Zadeh et al. BRAIN RESEARCH
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now